Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Allerzero
Korea Health Industry Development Institute (KHIDI) South Korea flag South Korea
Abstract ID:
asthma, atopic dermatitis, allergic rhinitis...
Contact Yong U Kim
Participants
You
Email me a copy of this message

The Company’s technology concentration includes research and development on natural substances that can be used in foods, medical supplies, cosmetics and daily products. With this base technology, the Company succeeded in commercializing a 100% natural substance-based acaricide product for house dust mites, which is a major cause of allergic disease such as asthma, atopic dermatitis and allergic rhinitis.


‘Allerzero,’ the dust mite extermination product that the Company developed, has various advantages in terms of side-effects, cost-effectiveness and convenience of use compared to other synthetic acaricides or laborious exterminating methods such as special vaccuums or professional services. In addition, as people show increasing concern and unease regarding allergic diseases caused by vermin, Allerzero is expected to show tremendous growth and attract much attention worldwide.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought
US6855348B2
FEATURED
Last Updated Jun 2016
Technology Type THERAPEUTIC
Phase of Development CLINICAL TRIALS
GOVERNMENT INSTITUTE